Skip to main content
Peptron, Inc. logo

Peptron, Inc. — Investor Relations & Filings

Ticker · 087010 ISIN · KR7087010005 KO Manufacturing
Filings indexed 226 across all filing types
Latest filing 2018-10-10 Investor Presentation
Country KR South Korea
Listing KO 087010

About Peptron, Inc.

http://www.peptron.com/

Peptron, Inc. is a biotechnology company specializing in peptide engineering and the development of sustained-release (SR) medications. The company's core focus is its proprietary SmartDepot platform technology, which enables the long-acting formulation of peptide-based drugs to treat chronic and life-threatening disorders. A key area of development is in neurodegenerative diseases, with a notable pipeline candidate being a sustained-release formulation of exenatide, based on patents exclusively licensed from the NIH. Peptron operates its own GMP-compliant manufacturing facility to produce its SR formulations, supporting its progression from pre-clinical research to commercial-stage development.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Investor Presentation Classification · 98% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, purpose, and target audience for the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it is under 5,000 characters, it falls under the category of a regulatory filing announcement regarding corporate events.
2018-10-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.